---
figid: PMC5814187__oncotarget-09-5958-g008
figtitle: Dock derived compound against laminin receptor (37 LR) exhibits anti-cancer
  properties in a prostate cancer cell line model
organisms:
- NA
pmcid: PMC5814187
filename: oncotarget-09-5958-g008.jpg
figlink: /pmc/articles/PMC5814187/figure/F8/
number: F8
caption: Significantly up and down regulated proteins were analyzed using Ingenuity
  Pathway Analysis Software and mapped to canonical pathways.
papertitle: A dock derived compound against laminin receptor (37 LR) exhibits anti-cancer
  properties in a prostate cancer cell line model.
reftext: Charles Samuel Umbaugh, et al. Oncotarget. 2018 Jan 19;9(5):5958-5978.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9461444
figid_alias: PMC5814187__F8
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5814187__F8
ndex: 4b02c987-dea7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5814187__oncotarget-09-5958-g008.html
  '@type': Dataset
  description: Significantly up and down regulated proteins were analyzed using Ingenuity
    Pathway Analysis Software and mapped to canonical pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MCM3
  - KPNA2
  - MCM4
  - ASNS
  - TP53
  - MCM6
  - WDHD1
  - UBE2C
  - FTH1
  - UBE2S
  - doxorubicin
---
